Lukas, Rimas V.
Rodon, Jordi
Becker, Kevin
Wong, Eric T.
Shih, Kent
Touat, Mehdi
Fassò, Marcella
Osborne, Stuart
Molinero, Luciana
O’Hear, Carol
Grossman, William
Baehring, Joachim
Funding for this research was provided by:
Roche
Article History
Received: 10 May 2018
Accepted: 16 July 2018
First Online: 2 August 2018
Compliance with ethical standards
:
: RVL has received support from Roche-Genentech for meeting travel to present study results, honoraria for advisory boards for AstraZeneca, Abbvie, and Ziopharm and honoraria for medical editing for EBSCO publishing, Medlink Neurology, and American Physician Institute. JR has received honoraria for advisory boards from Novartis, Lilly, Orion, Servier, and Peptomyc, and has received research funding from Bayer and Novartis. JB has received honoraria for advisory boards from BMS. MF is an employee of, and has stock options with Roche-Genentech, and has stock options and a patent with Aduro BioTech. CO and LM are employees of, and have stock options with Roche-Genentech. SO is an employee of Roche-Genentech. WG, MT, ETW, KS and KB have no conflicts to disclose.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.